Stock Spotlight Archives - Page 223 of 383

WednesdayOct 07, 2020 2:46 pm

QualityStocksNewsBreaks – Why VistaGen Therapeutics (NASDAQ: VTGN) Is ‘One to Watch’

VistaGen Therapeutics (NASDAQ: VTGN) is a biopharmaceutical company committed to developing and commercializing a new generation of medications that go beyond the standard of care for anxiety, depression and other central nervous system (“CNS”) disorders. Based out of South San Francisco, California, the “Birthplace of Biotechnology,” VistaGen is headquartered among the largest cluster of biotechnology companies in the world. A recent article discussing the company reads, “VistaGen currently has three innovative CNS drug candidates in its pipeline: PH94B, PH10 and AV-101. With a differentiated mechanism of action and an exceptional safety profile in all clinical studies to date, each of…

WednesdayOct 07, 2020 2:30 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd. Enters ‘Well-Timed Collaboration’ with AffPapa

Mobius Interactive, a new online gaming operator with a variety of diverse offerings, recently entered a new partnership with AffPapa, a unique platform that allows operators and affiliates to find each other. An article discussing this notes the “well-timed collaboration” designed to ease the process of finding partners and overcome challenges. “By joining our affiliate site with the AffPapa global affiliate and operator partnership platform, MobiusAffiliates.com will be a valuable addition to its affiliate directory, allowing space for significant exposure and growth over its critical launch period,” stated Mobius CEO Lynn Pearce. To view the full article, visit https://ibn.fm/LVemd About…

MondayOct 05, 2020 3:22 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Secures DOE Grant for Production of Rare Earth Elements

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, along with a team from Penn State University recently announced the award of a contract from the U.S. Department of Energy (“DOE”) Office of Fossil Energy (“FE”) and the National Energy Technology Laboratory (“NETL”). The government grant for an initial amount of $150,000 was awarded for the development of a design for the production of rare earth elements (“REEs”) from coal-based resources (https://ibn.fm/kMbwJ). If Energy Fuels is successful at the conceptual design phase, the DOE could award the company an additional $1.3 million to complete…

MondayOct 05, 2020 3:01 pm

QualityStocksNewsBreaks – Sustainable Green Team Ltd. (SGTM) Eyes Another Positive Quarter on Heels of Major Milestones

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has achieved several significant milestones as of late. These include the company’s receipt of permit approval to accept debris and manufacture mulch at its largest facility, located in Jacksonville (http://ibn.fm/yw8vR). “We are very pleased with our performance and direction,” stated SGTM CEO and director Tony Raynor in a recent article discussing the permit and SGTM’s financial results for the second quarter of 2020. “The positive recorded numbers were generated prior to achieving IPEMA certification for public surfacing material, which diversified our revenue…

FridayOct 02, 2020 2:27 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) CEO Discusses Strategic Business Models, Nascent Stage of B2C Platform

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which thrives on its business-to-business (“B2B”) model to provide radical transparency for drug pricing and availability while taking advantage of telehealth-friendly insurer policy shifts under its business-to-consumer (“B2C”) model. During his presentation, Ajjarapu highlighted comprehensive capabilities of the platform, including the vitality of its Bonum Health Hub portal-led B2C operations, serving approximately 15 million patients through the medium of over 11,700 independent pharmacies in its subscription…

FridayOct 02, 2020 1:56 pm

QualityStocksNewsBreaks – Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Shares Road Map to Production, Promising Drill Program Results

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B),a Delaware corporation engaged in the acquisition, exploration and development of U.S. gold and silver properties, laid out its plan to become a profitable gold producer at the Aug. 6 OTCQB Virtual Investor Conference. Bullfrog was one of several companies hand selected to present to individual and institutional investors, advisors and analysts attending the event. A recent article discusses BFGC’s presentation and plans as the company’s CEO David Beling outlined the exciting potential of the Bullfrog Mining District of Nevada — the prolific location of BFGC properties — as well as promising…

FridayOct 02, 2020 1:43 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd., UltraPlay to Enhance Customer Engagement Through Loyalty, Gamification Programs and Cutting-Edge Tech

Mobius Interactive, a new online gaming operator with a variety of diverse offerings, has partnered with leading eSports and iGaming platform — UltraPlay — to attract a global network of high-net-worth gamers. The two companies are collaborating to enhance customer engagement through the use of loyalty and gamification programs. A recent article discussing this reads, “Currently, Mobius is partnering with UltraPlay to offer more than 34 unique games and sports betting available 24/7. Mobius’ sports betting product has a wide range of functionalities, mystery jackpots, cutting-edge tech and live and pre-match odds. In addition, the company’s live casino games are…

FridayOct 02, 2020 1:28 pm

QualityStocksNewsBreaks – Cybin Corp. CEO Eyes Opportunity in Psychedelics Space, Organic IP Expansion

Cybin Corp., a Canada-based, life-science company developing mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products, recently announced the appointment of Doug Drysdale as the company’s chief executive officer. Well recognized in the pharmaceutical space, Drysdale brings more than three decades of experience and a recognition of psychedelics as a major breakthrough in treating mental health conditions. Amid the recent strong push for research and commercialization in the psychedelics sector, Drysdale seeks to pursue emerging opportunities and pave the road for the company’s rapid growth. “I am beyond excited to be joining the Cybin team,” Drysdale stated in a recent article of…

FridayOct 02, 2020 1:07 pm

QualityStocksNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics CIO Discusses Convergence of AI, Data and Biology on DojoLIVE!

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, was featured in a recent article discussing the appearance of one of its executives, Helomics CIO Mark Collins, PhD, on DojoLIVE! (https://ibn.fm/Y9fBZ). POAI’s Helomics subsidiary applies AI to its rich data gathered from more than 150,000 tumors in an effort to personalize cancer therapies and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Collins addressed this powerful work and his longtime passion during the interview titled, “Can We Cure Cancer with Artificial Intelligence?” “The last 20 years of…

FridayOct 02, 2020 12:46 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. Setting the Stage for Success in Bringing Novel Products to Market

180 Life Sciences, a clinical-stage biotechnology company, is focused on research to solve one of the world’s most significant drivers of disease – inflammation. The company currently has three programs for the development of novel drugs in the areas of fibrosis and anti-TNF, inflammatory pain and ulcerative colitis in ex-smokers. A recent article discusses the company’s strategy to expedite the path to market. The piece reads, “180 Life Sciences has mitigated the risks of its drug development through multiple programs at various stages of development. The company is actively decreasing costs and expediting the time to market by using grant…

Site Search

Company Search

Category: Stock Spotlight